Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm
Recruiting
N/A
Interventional Study
Stomach Neuroendocrine Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 60 (estimated)
- Sponsor
- Asian Institute of Gastroenterology, India · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study objectives:
Primary objective:
1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm.
Secondary objectives:
To evaluate:
1. En bloc resection rate
2. Immediate and delayed adverse events
3. Procedure time
4. Histologic quality of resection (deep and lateral margins)
5. Residual disease at resection scar on surveillance endoscopy oMetachronous g…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patient-level
* Age ≥18 years
* Fit for endoscopic therapy and sedation
* Written informed consent
Exclusion Criteria:
Lesion-level
* Endoscopically visible gastric neuroendocrine tumor
* Size 5-9 mm (endoscopic estimation)
* Clinical and/or histologic features consistent wi…
Contacts